Assembly Biosciences ASMB
NASDAQ ASMB
$20.46 -0.73 (-3.45%)
At close: Oct 21, 2026 · 4:00 PM EDT

Assembly Biosciences (ASMB) Debt Ratio (2010 - 2011)

Updated

Assembly Biosciences' (ASMB) Debt Ratio was 0.11 for Q2 2011.

Analysis

Assembly Biosciences (ASMB) Debt Ratio (2010 - 2011) Analysis & Trends

For FY2010, Debt Ratio at Assembly Biosciences was 0.17.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Assembly Biosciences 386.12 Mn -641.50 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2011 0.11
Dec 31, 2010 0.17
API Access

Assembly Biosciences Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=ASMB&period=max&api_key=YOUR_API_KEY